These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 17227287)

  • 1. Augmentation treatment of psychotherapy for anxiety disorders with D-cycloserine.
    Hofmann SG; Pollack MH; Otto MW
    CNS Drug Rev; 2006; 12(3-4):208-17. PubMed ID: 17227287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing exposure-based therapy from a translational research perspective.
    Hofmann SG
    Behav Res Ther; 2007 Sep; 45(9):1987-2001. PubMed ID: 17659253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmentation of cognitive behavioral therapy with pharmacotherapy.
    Ganasen KA; Ipser JC; Stein DJ
    Psychiatr Clin North Am; 2010 Sep; 33(3):687-99. PubMed ID: 20599140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D-cycloserine augmentation of cognitive behavioral therapy for anxiety disorders: an update.
    Hofmann SG; Otto MW; Pollack MH; Smits JA
    Curr Psychiatry Rep; 2015 Jan; 17(1):532. PubMed ID: 25413638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy.
    Norberg MM; Krystal JH; Tolin DF
    Biol Psychiatry; 2008 Jun; 63(12):1118-26. PubMed ID: 18313643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear.
    Ressler KJ; Rothbaum BO; Tannenbaum L; Anderson P; Graap K; Zimand E; Hodges L; Davis M
    Arch Gen Psychiatry; 2004 Nov; 61(11):1136-44. PubMed ID: 15520361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmentation of exposure therapy with D-cycloserine for social anxiety disorder.
    Hofmann SG; Meuret AE; Smits JA; Simon NM; Pollack MH; Eisenmenger K; Shiekh M; Otto MW
    Arch Gen Psychiatry; 2006 Mar; 63(3):298-304. PubMed ID: 16520435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose timing of D-cycloserine to augment cognitive behavioral therapy for social anxiety: Study design and rationale.
    Hofmann SG; Carpenter JK; Otto MW; Rosenfield D; Smits JA; Pollack MH
    Contemp Clin Trials; 2015 Jul; 43():223-30. PubMed ID: 26111923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extinction learning as a moderator of d-cycloserine efficacy for enhancing exposure therapy in posttraumatic stress disorder.
    de Kleine RA; Smits JA; Hendriks GJ; Becker ES; van Minnen A
    J Anxiety Disord; 2015 Aug; 34():63-7. PubMed ID: 26121495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valproic acid but not D-cycloserine facilitates sleep-dependent offline learning of extinction and habituation of conditioned fear in humans.
    Kuriyama K; Honma M; Yoshiike T; Kim Y
    Neuropharmacology; 2013 Jan; 64():424-31. PubMed ID: 22992332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does D-cycloserine enhance exposure therapy for anxiety disorders in humans? A meta-analysis.
    Rodrigues H; Figueira I; Lopes A; Gonçalves R; Mendlowicz MV; Coutinho ES; Ventura P
    PLoS One; 2014; 9(7):e93519. PubMed ID: 24991926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D-cycloserine as an augmentation strategy for cognitive behavioral therapy for anxiety disorders: an update.
    Hofmann SG; Sawyer AT; Asnaani A
    Curr Pharm Des; 2012; 18(35):5659-62. PubMed ID: 22632472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMDA receptors and fear extinction: implications for cognitive behavioral therapy.
    Davis M
    Dialogues Clin Neurosci; 2011; 13(4):463-74. PubMed ID: 22275851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized controlled trial of the effect of D-cycloserine on exposure therapy for spider fear.
    Guastella AJ; Dadds MR; Lovibond PF; Mitchell P; Richardson R
    J Psychiatr Res; 2007 Sep; 41(6):466-71. PubMed ID: 16828803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of D-cycloserine on extinction: translation from preclinical to clinical work.
    Davis M; Ressler K; Rothbaum BO; Richardson R
    Biol Psychiatry; 2006 Aug; 60(4):369-75. PubMed ID: 16919524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of Psychosocial Treatment With D-Cycloserine: Models, Moderators, and Future Directions.
    Otto MW; Kredlow MA; Smits JAJ; Hofmann SG; Tolin DF; de Kleine RA; van Minnen A; Evins AE; Pollack MH
    Biol Psychiatry; 2016 Aug; 80(4):274-283. PubMed ID: 26520240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroimaging correlates of pharmacological and psychological treatments for specific phobia.
    Linares IM; Chags MH; Machado-de-Sousa JP; Crippa JA; Hallak JE
    CNS Neurol Disord Drug Targets; 2014; 13(6):1021-5. PubMed ID: 24923351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. D-cycloserine in Schizophrenia: New Strategies for Improving Clinical Outcomes by Enhancing Plasticity.
    Goff DC
    Curr Neuropharmacol; 2017; 15(1):21-34. PubMed ID: 26915421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D-cycloserine does not facilitate fear extinction by reducing conditioned stimulus processing or promoting conditioned inhibition to contextual cues.
    Baker KD; McNally GP; Richardson R
    Learn Mem; 2012 Sep; 19(10):461-9. PubMed ID: 22984284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurobiology of anxiety disorders and implications for treatment.
    Garakani A; Mathew SJ; Charney DS
    Mt Sinai J Med; 2006 Nov; 73(7):941-9. PubMed ID: 17195879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.